ID   SK3/VP16
AC   CVCL_Y203
DR   CGH-DB; 9124-4
DR   Wikidata; Q54954658
RX   PubMed=14973057;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7005 ! ACC-LC-172
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
RX   PubMed=14973057; DOI=10.1158/0008-5472.CAN-3263-2;
RA   Yasui K., Mihara S., Zhao C., Okamoto H., Saito-Ohara F., Tomida A.,
RA   Funato T., Yokomizo A., Naito S., Imoto I., Tsuruo T., Inazawa J.;
RT   "Alteration in copy numbers of genes as a mechanism for acquired drug
RT   resistance.";
RL   Cancer Res. 64:1403-1410(2004).
//